NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Instil Bio, Inc. (NASDAQ: TIL) resulting from allegations that Instil Bio may have issued materially misleading business information to the investing public. SO WHAT: If you […]

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November 21, 2022 lead plaintiff deadline. SO WHAT: If […]

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twitter, Inc. (NYSE: TWTR) between August 3, 2020 and August 23, 2022, both dates inclusive (the “Class Period”), of the important November 14, 2022 lead plaintiff deadline in the securities class […]